induced pluripotent stem cell-derived cardiomyocyte therapy (Fujifilm/Takeda)

N/A

Report date: 2025/03/20 15:25:33

Base Information

Drug Nameinduced pluripotent stem cell-derived cardiomyocyte therapy (Fujifilm/Takeda)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Cardiac myocyte stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFujifilm Holdings Corp
China Registration ClassN/A

Develop Information

Active CompaniesFujifilm Holdings CorpTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A